Gallage, Nethaji J.
Hansen, Esben H.
Kannangara, Rubini
Olsen, Carl Erik
Motawia, Mohammed Saddik
Jørgensen, Kirsten
Holme, Inger
Hebelstrup, Kim
Grisoni, Michel
Møller, Birger Lindberg
Article History
Received: 19 November 2013
Accepted: 6 May 2014
First Online: 19 June 2014
Competing interests
: The biotech company Evolva A/S has developed a yeast-based production platform for synthesis of vanillin glucoside from glucose (ref. CitationRef removed). Esben H. Hansen is a research employee at Evolva and Birger Lindberg Møller is on the Science Advisory Board of Evolva. The remaining authors declare no competing financial interests.